Language
English
Publication Date
12-29-2023
Journal
Cellular and Molecular Life Sciences
DOI
10.1007/s00018-023-05080-4
PMID
38157020
PMCID
PMC10756874
PubMedCentral® Posted Date
12-29-2023
PubMedCentral® Full Text Version
Post-print
Abstract
Idiopathic pulmonary fibrosis (IPF) is a fatal and devastating lung disease of unknown etiology, described as the result of multiple cycles of epithelial cell injury and fibroblast activation. Despite this impressive increase in understanding, a therapy that reverses this form of fibrosis remains elusive. In our previous study, we found that miR-29b has a therapeutic effect on pulmonary fibrosis. However, its anti-fibrotic mechanism is not yet clear. Recently, our study identified that F-Actin Binding Protein (TRIOBP) is one of the target genes of miR-29b and found that deficiency of TRIOBP increases resistance to lung fibrosis in vivo. TRIOBP knockdown inhibited the proliferation of epithelial cells and attenuated the activation of fibroblasts. In addition, deficiency of Trio Rho Guanine Nucleotide Exchange Factor (TRIO) in epithelial cells and fibroblasts decreases susceptibility to lung fibrosis. TRIOBP interacting with TRIO promoted abnormal epithelial-mesenchymal crosstalk and modulated the nucleocytoplasmic translocation of β-catenin. We concluded that the miR-29b‒TRIOBP-TRIO-β-catenin axis might be a key anti-fibrotic axis in IPF to regulate lung regeneration and fibrosis, which may provide a promising treatment strategy for lung fibrosis.
Keywords
Animals, Humans, Mice, beta Catenin, Fibroblasts, Fibrosis, Idiopathic Pulmonary Fibrosis, Lung, Mice, Inbred C57BL, Microfilament Proteins, MicroRNAs, Signal Transduction
Published Open-Access
yes
Recommended Citation
Wang, Lan; Zhao, Wenyu; Xia, Cong; et al., "Triobp Modulates β-Catenin Signaling by Regulation of miR-29b in Idiopathic Pulmonary Fibrosis" (2023). Faculty, Staff and Students Publications. 2042.
https://digitalcommons.library.tmc.edu/baylor_docs/2042
Graphical Abstract
Included in
Biological Phenomena, Cell Phenomena, and Immunity Commons, Life Sciences Commons, Medical Cell Biology Commons, Medical Microbiology Commons, Medical Molecular Biology Commons, Medical Specialties Commons